Company / Current Assets per Share
GT Biopharma, Inc. Current Assets per Share History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.38
FY2020
5-year range
$0.00 / $5.53
FY2016-FY2020
Trend
-75.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2013 to $5.53 in FY2017.
Based on SEC 10-K filings.
1.38 in FY2020 with a 5-year CAGR of +29.9%.
Improved from $0.02 to $1.38 over the past 4 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -37.0%
- 5-Year CAGR
- +29.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, current assets per share decreased 75.0% year-over-year.
- Peak current assets per share was recorded in FY2017.
- Lowest current assets per share in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $1.38 | -75.0% |
| FY2017 | $5.53 | +26970.4% |
| FY2016 | $0.02 | -94.5% |
| FY2015 | $0.37 | +24114.2% |
| FY2014 | $0.00 | +516.4% |
| FY2013 | $0.00 | -66.7% |
| FY2012 | $0.00 | +7.9% |
| FY2011 | $0.00 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026